GluSense Overview

  • Founded

  • 2007

Founded
  • Status

  • Private

  • Employees

  • 6

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 10

GluSense General Information

Description

Developer of an implantable glucose sensor designed to achieve glycemic balance for a better life. The company's glucose sensor is a minimally invasive device that offers accurate glucose measurement for a full year with significantly fewer blood glucose calibrations, wirelessly through a wearable device such as a watch, enabling people with diabetes to maintain blood glucose levels in a safe range.

Contact Information

Website
www.glusensemedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 3 Pekeris Street, Ruhrberg Science Center
  • Edison entrance, Floor 4, Rabin Science Park
  • Rehovot 76702
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GluSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 000 Completed Generating Revenue
2. Later Stage VC 15-Feb-2017 000 000 Completed Generating Revenue
1. Later Stage VC (Series C) 01-Sep-2014 $5M $5M Completed Generating Revenue
To view GluSense’s complete valuation and funding history, request access »

GluSense Patents

  • 30

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GluSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3445872-A1 Fret-based glucose-detection molecules Inactive 20-Apr-2016 0000000000
US-10871487-B2 Fret-based glucose-detection molecules Active 20-Apr-2016 0000000000 000
US-20190128879-A1 Fret-based glucose-detection molecules Active 20-Apr-2016 0000000000 0
US-20170100598-A1 Implant illumination Inactive 13-Oct-2015 0000000000 0
US-10575765-B2 Analyte-sensing device Active 13-Oct-2014 A61B5/14556 000
To view GluSense’s complete patent history, request access »

GluSense Executive Team (6)

Name Title Board Seat Contact Info
William Tamborlane Advisor
Boaz Brill Ph.D Chief Executive Officer
Uriel Barkai Ph.D Chief Scientific Officer
Yossi Gross Founder & Board Member
You’re viewing 4 of 6 executive team members. Get the full list »

GluSense Board Members (4)

Name Representing Role Since
Ilan Neugarten Rainbow Medical Innovation Chairman 000 0000
Jiang Zhang Ping An Ventures Board Member 000 0000
Yossi Gross Self Founder & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

GluSense Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GluSense Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
T1D Fund Venture Capital Minority 000 0000 000000 0
GlenRock Israel Growth/Expansion Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
Keytone Ventures Venture Capital Minority 000 0000 000000 0
OXO Capital Valve Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial